Skip to Content

M GP5 (Glipizide Extended-Release 5 mg)

Pill with imprint M GP5 is White, Round and has been identified as Glipizide Extended-Release 5 mg. It is supplied by Mylan Pharmaceuticals Inc..

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M GP5

Glipizide extended-release 5 mg M GP5

Glipizide Extended-Release

Imprint:
M GP5
Strength:
5 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0342

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide